For tens of thousands of years human babies have been vaginally delivered and nourished by human breast milk. Ironically, modern birthing , nutrition, and hygiene practices in the US and other western societies have resulted in infants with higher rates of respiratory, GI disorders, and hyper-allergenic responses than corresponding infants in many emerging nations. This has now been correlated to the type and diversity of the microflora in the baby’s GI tract that is originally obtained from direct contact with the mother.
It is now clearly established that a healthy gut microbiota is paramount to the general health of individuals. Establishing the health of the gut in infants is important for the proper development of the adult gut microbiota. Evolve’s scientists have discovered a link between human milk and a specific bacteria that makes up as much as 80% of the microbiome in a healthy breast-fed babies in the first 6 months of life. Based on the team’s expertise in prebiotics, probiotics, and their interactions, Evolve is developing a proprietary and effective probiotic bacteria, activated with specific prebiotic oligosaccharides and delivery systems to provide and maintain a healthy microbiome in all infants during the first 6 months of life.